Azelaic Acid: One Ingredient for Acne, Rosacea, and Melasma
INGREDIENTS

Azelaic Acid: One Ingredient for Acne, Rosacea, and Melasma

By Soo · · PMC / J Cosm Dermatol
KO | EN

Finding one ingredient that addresses acne, rosacea, and melasma is uncommon. Most actives are specialized: retinoids for cell turnover, benzoyl peroxide for bacterial acne, hydroquinone for pigmentation. Azelaic acid is different. A review published in the Journal of Cosmetic Dermatology consolidates the clinical evidence and explains why a single dicarboxylic acid manages to address three distinct skin conditions through five independent mechanisms.

Five Mechanisms in One Molecule

Azelaic acid is a naturally occurring nine-carbon dicarboxylic acid found in grains including wheat, rye, and barley. In the skin, it engages five separate pathways simultaneously.

Antibacterial: Inhibits protein synthesis in P. acnes, the primary bacteria driving inflammatory acne, without developing resistance patterns seen with topical antibiotics.

Anti-keratinizing: Normalizes abnormal follicular keratinization, reducing comedone formation. The action is analogous to retinoid effects but with substantially less irritation.

Melanin-inhibiting: Blocks tyrosinase, the rate-limiting enzyme in melanin synthesis, while selectively targeting overactive melanocytes. Normal pigmentation is unaffected.

Antioxidant: Neutralizes reactive oxygen species that drive oxidative skin damage and amplify inflammatory cascades.

Anti-inflammatory: Suppresses cytokine pathways mediating erythema and papule formation, the two defining features of rosacea.

Clinical Numbers by Indication

Acne: Azelaic acid 20% produced a 70% reduction in comedones versus 14% for vehicle control. The proportion of participants rated as showing “good to excellent” improvement reached 64% in the azelaic acid group compared to 36% in the vehicle group.

Rosacea: Azelaic acid 15% gel outperformed metronidazole 0.75% — the longstanding first-line rosacea treatment — across all three measured outcomes: erythema, inflammatory lesion count, and overall improvement rating.

Melasma: In head-to-head comparison with hydroquinone 4%, azelaic acid 20% cream demonstrated equivalent pigmentation reduction. The advantage was in the safety profile — hydroquinone can cause paradoxical hyperpigmentation with long-term use, while azelaic acid’s selective mechanism avoids this risk.

What the Market Numbers Reflect

The azelaic acid market reached approximately $200 million in 2023 and is projected to grow to $415 million by 2033. The growth trajectory reflects a shift in how consumers and clinicians approach multi-concern skin. An ingredient that addresses the overlap between acne, rosacea, and hyperpigmentation without the risk profiles of prescription alternatives has a naturally expanding application.

FDA approval covers azelaic acid 15% gel for rosacea and 20% gel or cream for acne. These designations represent prescription pharmaceutical standards of evidence, not cosmetic claims.

Practical Application

Azelaic acid is suitable for morning and evening use. It carries a Pregnancy Category B classification, placing it among the rare effective prescription actives considered acceptable during pregnancy. Its tolerability profile is gentler than retinol and AHA/BHA combinations, supporting long-term consistent use.

Early use may produce mild tingling or transient dryness. Starting with every-other-day application, then advancing to daily use over two to three weeks, minimizes this initial phase. Combining with niacinamide or ceramide-containing moisturizers provides additional barrier support. Sunscreen is essential alongside any ingredient addressing pigmentation, as UV exposure will counteract melanin-reducing effects.